Product Details

Neomycin + Polymyxin B + Dexamethasone 0.5% + 10,000 IU/g + 0.1% Cream/Ointment delivers a high-quality topical combination therapy formulated to Indian Pharmacopoeia (IP) standards. This fixed-dose triple combination manages inflammatory skin conditions complicated by bacterial infection, combining broad-spectrum antibacterial coverage with potent anti-inflammatory action in a single topical preparation.

The cream/ointment combines:

• Neomycin, an aminoglycoside antibiotic that eliminates bacterial skin infections by inhibiting bacterial protein synthesis,
• Polymyxin B, a polypeptide antibiotic that targets gram-negative bacteria by disrupting bacterial cell membrane integrity, extending antibacterial coverage alongside Neomycin, and
• Dexamethasone, a corticosteroid that reduces inflammation, redness, and itching by suppressing the local inflammatory response.

Doctors commonly prescribe this combination for infected dermatitis, eczema, and other inflammatory skin conditions complicated by secondary bacterial infection, where broader antibacterial coverage is needed. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• IP-standard compliant topical triple combination therapy
• Treats inflammatory skin conditions with bacterial infection
• Delivers broad-spectrum antibacterial and potent anti-inflammatory action
• Contains Neomycin 0.5% + Polymyxin B 10,000 IU/g + Dexamethasone 0.1% per gram
• Maintains a high-purity, stable formulation
• Convenient 15 g tube for topical application
• Suits hospital, clinical, and pharmacy use